Authors
Jaana Isojärvi
Last updated: 5 March 2025
What's new in this update
No new research relevant to the chapter was identified during the March 2025 update.
Introduction
This domain describes the target conditions, target groups, epidemiology and the availability and patterns of use of the technology in question. Furthermore, the domain addresses the burden – both on individuals and on the society – caused by the health problem, the alternatives to the technology in question, as well as the regulatory status of the technology and the requirements for its use. It covers the qualitative description of the target condition, including the underlying mechanism (pathophysiology), natural history (i.e. course of disease), available screening and diagnostic methods, prognosis, and epidemiology (incidence, prevalence), as well as the underlying risk factors for acquiring the condition as well as available treatments. A description of subgroups or special indications should be included especially in the case when the technology does not target the whole population. (EUnetHTA 2016)
Sources to search
Review articles and textbooks can be helpful for finding information about the history and characteristics of established technology.
Health sciences databases (e.g. MEDLINE, Embase, The Cochrane Library, CRD databases, Cinahl, BIOSIS, PsycInfo)
Social sciences databases (e.g. Sociological Abstracts, Social Care Online, ASSIA)
General science publishers' databases (e.g. ScienceDirect, Ebsco Academic Search Elite, PubMed Central, BioMed Central)
Other databases (e.g. ERIC, Joanna Briggs Institute, WHO, OECD)
Ongoing research databases (e.g. ClinicalTrials.gov, EunetHTA POP Database, Prospero)
Horizon scanning databases (e.g. Euroscan)
Grey literature (e.g. OAIster, Dissertation Abstracts)
Registers and statistics (e.g. disease registers, national screening registers, pharmaceutical registers, routinely collected statistics and administrative data)
Websites (e.g. patient associations, manufacturers, regulatory institutions)
Other sources (e.g. market research reports, industry, expert opinions, national and regional guidelines, norms and regulations)
(EUnetHTA 2016)
Designing search strategies
Methodologies familiar from clinical or HTA research are not suitable for finding proper up-to-date answers for questions of this domain. It may be much faster and more efficient to collect a proper background set of information through an international survey among HTA agencies, health ministries or health service providers, rather than to perform extensive literature searches. If a literature search is conducted, basic principles of systematic review methodology should be followed. (EUnetHTA 2016)
Reference list
EUnetHTA Joint Action 2, Work Package 8. HTA Core Model® version 3.0; 2016 (pdf). [Publication appraisal]
Please note that this chapter is based entirely on the "Health problem and current use of technology" section of the HTA Core Model, which is no longer available online after EUnetHTA ceased operations.
For further information about the HTA Core Model, please see:
Kristensen FB, Lampe K, Wild C, Cerbo M, Goettsch W, Becla L. The HTA Core Model®—10 Years of Developing an International Framework to Share Multidimensional Value Assessment. Value in Health. 2017; 20(2): 244-250
and
Lampe K, Mäkelä M, Garrido MV, et al. The HTA Core Model: A novel method for producing and reporting health technology assessments. International Journal of Technology Assessment in Health Care. 2009;25(S2):9-20. doi:10.1017/S0266462309990638
How to cite this chapter:
Isojarvi J. Health problem and current use of the technology. Last updated 5 March 2025. In: SuRe Info: Summarized Research in Information Retrieval for HTA. Available from: https://www.sure-info.org//health-problem-and-current-use-of-the-technology
Copyright: the authors